CRISPR trials are about to begin in people—but we still don’t know how well it works in monkeys – MIT Technology Review
MIT Technology Review |
CRISPR trials are about to begin in people—but we still don't know how well it works in monkeys
MIT Technology Review Some of the first CRISPR experiments in monkeys involve blood disorders like sickle-cell disease and beta thalassemia. CRISPR could be ideal for both diseases, scientists think, because each is caused by mutations in a single gene that makes hemoglobin … Why FDA's proposed gene-editing regulations could stifle CRISPR research on food animals Can the Gene-Editing Technology CRISPR Cure This Debilitating Brain Disease? |
